NEW YORK ( TheStreet) -- CHANGE IN RATINGSAdobe Systems ( ADBE) downgraded at Jefferies to Hold from Buy, Jefferies said. $32 price target. Too much change to navigate comfortably. Best Buy ( BBY) upgraded at Citigroup to Neutral from Sell, Citigroup said. $21 price target. More balanced risk/reward after 35% pullback. Beneficial Mutual Bancorp ( BNCL) downgraded to hold at TheStreet Ratings. Clean Energy Fuels ( CLNE) downgraded to sell at TheStreet Ratings. Human Genome ( HGSI) downgraded at JMP from Outperform to Market Perform, JMP Securities said. Benlysta likely faces an uphill battle to gain adoption for doctors treating lupus. Immunogen ( IMGN) rated new Hold at Cantor. $15 price target. Stock is already factoring in commercial revenue expected from Roche deal. Nike ( NKE) upgraded at McAdams from Sell to Hold, McAdams Wright Ragen said. Stock has pulled back to a fair value.
STOCK COMMENTS / EPS CHANGES
Boeing ( BA) estimates lowered at UBS through 2013, UBS said. Gauging MAX impact on BCA margins. Neutral rating and $72 price target. Crane ( CR) estimates, target reduced at Keybanc. CR estimates were cut through 2013, Keybanc said. Strong dollar and lower commecial demand could hurt near-term results. Buy rating and new $50 price target. Ctrip.com International ( CTRP) estimates lowered at Oppenheimer through 2013, Oppenheimer said. Impact of the PRC withholding tax. Outperform rating. Discover Financial Services ( DFS) numbers raised at Citigroup. Shares of DFS now seen reaching $35, Citigroup said. Estimates also increased to reflect better card credit. Neutral rating. Equifax ( EFX) estimates, target raised at Credit Suisse. Shares of EFX now seen reaching $50, according to Credit Suisse. Estimates also increased, as the company can likely sustain solid organic sales growth, despite difficult macro conditions. Neutral rating. Edward Lifesciences ( EW) target raised at Jefferies. Shares of EW now seen reaching $100, Jefferies said. Positive panel paves way for Sapien Label expansion. Buy rating. Edwards Lifesciences target boosted at BMO. Shares of EW now seen reaching $94, according to BMO Capital. FDA panel was strongly in favor of approving Cohort A. Market Perform rating. Jabil Circuit ( JBL) numbers cut at Citigroup. Shares of JBL now seen reaching $21, Citigroup said. Estimates also lowered given disappointing outlooks from major customers. Neutral rating. JC Penney ( JCP) target cut at Morgan Stanley to $22, according to Morgan Stanley. Survey suggests a weaker consumer pricing environment. Underweight rating.